Document is current
Any future updates will be listed below
-
Authors
Sarasso, Elisabetta https://orcid.org/0000-0002-5300-2849
Basaia, Silvia
Cividini, Camilla
Stojkovic, Tanja
Stankovic, Iva
Piramide, Noemi
Tomic, Aleksandra
Markovic, Vladana
Stefanova, Elka
Kostic, Vladimir S.
Filippi, Massimo https://orcid.org/0000-0002-5485-0479
Agosta, Federica
-
Funding
Funding for this research was provided by:
Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja (175090)
Ministero della Salute (RF-2018-12366746)
- License Information
-
More Information
Article History
Received: 28 February 2022
Accepted: 31 October 2022
First Online: 15 November 2022
Competing interests
: F.A. is Section Editor of <i>NeuroImage: Clinical</i>; received compensation for consulting services and/or speaking activities from Philips, Novartis, Biogen Idec and Roche; and receives or has received research supports from the Italian Ministry of Health, AriSLA (Fondazione Italiana di Ricerca per la SLA), the European Research Council and Foundation Research on Alzheimer Disease. T.S. and E.S. have received Alzheimer Association grant for Promoting Diversity, from 2018 and honoraria from Actavis. A.T. has received honoraria for serving as a consultant to and on the advisory board of Univar BV. V.S. Kostic has received speaker honoraria from Roche and Alkaloid and receives research supports from the Swiss Pharm and Serbian Ministry of Education, Science, and Development and Serbian Academy of Sciences and Art. M.F. is Editor-in-Chief of the <i>Journal of Neurology</i> and Associate Editor of <i>Human Brain Mapping</i>; received compensation for consulting services and/or speaking activities from Almiral, Alexion, Bayer, Biogen, Celgene, Eli Lilly, Genzyme, Merck-Serono, Novartis, Roche, Sanofi, Takeda, and Teva Pharmaceutical Industries; and receives research support from Biogen Idec, Merck-Serono, Novartis, Roche, Teva Pharmaceutical Industries, Italian Ministry of Health, Fondazione Italiana Sclerosi Multipla, and ARiSLA (Fondazione Italiana di Ricerca per la SLA). The other authors declare no competing interests.
